Literature DB >> 28424283

Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets.

Masayuki Fujino1, Hirotaka Sato1,2, Tomotaka Okamura2, Akihiko Uda3, Satoshi Takeda1, Nursarat Ahmed1,2, Shigeyuki Shichino4, Teiichiro Shiino5, Yohei Saito1,2, Satoru Watanabe1,2, Chie Sugimoto6, Marcelo J Kuroda6, Manabu Ato7, Yoshiyuki Nagai8, Shuji Izumo9, Kouji Matsushima4, Masaaki Miyazawa10, Aftab A Ansari11, Francois Villinger11,12, Kazuyasu Mori13,2.   

Abstract

Glycosylation of Env defines pathogenic properties of simian immunodeficiency virus (SIV). We previously demonstrated that pathogenic SIVmac239 and a live-attenuated, quintuple deglycosylated Env mutant (Δ5G) virus target CD4+ T cells residing in different tissues during acute infection. SIVmac239 and Δ5G preferentially infected distinct CD4+ T cells in secondary lymphoid organs (SLOs) and within the lamina propria of the small intestine, respectively (C. Sugimoto et al., J Virol 86:9323-9336, 2012, https://doi.org/10.1128/JVI.00948-12). Here, we studied the host responses relevant to SIV targeting of CXCR3+ CCR5+ CD4+ T cells in SLOs. Genome-wide transcriptome analyses revealed that Th1-polarized inflammatory responses, defined by expression of CXCR3 chemokines, were distinctly induced in the SIVmac239-infected animals. Consistent with robust expression of CXCL10, CXCR3+ T cells were depleted from blood in the SIVmac239-infected animals. We also discovered that elevation of CXCL10 expression in blood and SLOs was secondary to the induction of CD14+ CD16+ monocytes and MAC387+ macrophages, respectively. Since the significantly higher levels of SIV infection in SLOs occurred with a massive accumulation of infiltrated MAC387+ macrophages, T cells, dendritic cells (DCs), and residential macrophages near high endothelial venules, the results highlight critical roles of innate/inflammatory responses in SIVmac239 infection. Restricted infection in SLOs by Δ5G also suggests that glycosylation of Env modulates innate/inflammatory responses elicited by cells of monocyte/macrophage/DC lineages.IMPORTANCE We previously demonstrated that a pathogenic SIVmac239 virus and a live-attenuated, deglycosylated mutant Δ5G virus infected distinct CD4+ T cell subsets in SLOs and the small intestine, respectively (C. Sugimoto et al., J Virol 86:9323-9336, 2012, https://doi.org/10.1128/JVI.00948-12). Accordingly, infections with SIVmac239, but not with Δ5G, deplete CXCR3+ CCR5+ CD4+ T (Th1) cells during the primary infection, thereby compromising the cellular immune response. Thus, we hypothesized that distinct host responses are elicited by the infections with two different viruses. We found that SIVmac239 induced distinctly higher levels of inflammatory Th1 responses than Δ5G. In particular, SIVmac239 infection elicited robust expression of CXCL10, a chemokine for CXCR3+ cells, in CD14+ CD16+ monocytes and MAC387+ macrophages recently infiltrated in SLOs. In contrast, Δ5G infection elicited only modest inflammatory responses. These results suggest that the glycosylation of Env modulates the inflammatory/Th1 responses through the monocyte/macrophage subsets and elicits marked differences in SIV infection and clinical outcomes.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CD4+ T cell; CXCL10; CXCR3; SIV; Th1; glycosylation; innate immunity; macrophages; monocytes; pathogenesis

Mesh:

Substances:

Year:  2017        PMID: 28424283      PMCID: PMC5469254          DOI: 10.1128/JVI.00439-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Recently infiltrating MAC387(+) monocytes/macrophages a third macrophage population involved in SIV and HIV encephalitic lesion formation.

Authors:  Caroline Soulas; Cecily Conerly; Woong-Ki Kim; Tricia H Burdo; Xavier Alvarez; Andrew A Lackner; Kenneth C Williams
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

3.  Accumulation of MAC387+ macrophages in paracortical areas of lymph nodes in rhesus monkeys acutely infected with simian immunodeficiency virus.

Authors:  I Otani; K Mori; T Sata; K Terao; K Doi; H Akari; Y Yoshikawa
Journal:  Microbes Infect       Date:  1999-10       Impact factor: 2.700

4.  Epigenetic regulation of tumor necrosis factor α (TNFα) release in human macrophages by HIV-1 single-stranded RNA (ssRNA) is dependent on TLR8 signaling.

Authors:  Xinbing Han; Xin Li; Simon C Yue; Asha Anandaiah; Falah Hashem; Peter S Reinach; Henry Koziel; Souvenir D Tachado
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

5.  The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38 activation pathway.

Authors:  Jesus M Salvador; Paul R Mittelstadt; Galina I Belova; Albert J Fornace; Jonathan D Ashwell
Journal:  Nat Immunol       Date:  2005-02-27       Impact factor: 25.606

6.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

8.  Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain.

Authors:  Maria E Moreno-Fernandez; Wildeman Zapata; Jason T Blackard; Genoveffa Franchini; Claire A Chougnet
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

9.  Innate sensing of HIV-infected cells.

Authors:  Alice Lepelley; Stéphanie Louis; Marion Sourisseau; Helen K W Law; Julien Pothlichet; Clémentine Schilte; Laurence Chaperot; Joël Plumas; Richard E Randall; Mustapha Si-Tahar; Fabrizio Mammano; Matthew L Albert; Olivier Schwartz
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

Review 10.  Cytosolic sensing of viruses.

Authors:  Delphine Goubau; Safia Deddouche; Caetano Reis e Sousa
Journal:  Immunity       Date:  2013-05-23       Impact factor: 31.745

View more
  3 in total

1.  Critical Role for Monocytes/Macrophages in Rapid Progression to AIDS in Pediatric Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Chie Sugimoto; Kristen M Merino; Atsuhiko Hasegawa; Xiaolei Wang; Xavier A Alvarez; Hiroshi Wakao; Kazuyasu Mori; Woong-Ki Kim; Ronald S Veazey; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Protective Immune Responses Elicited by Deglycosylated Live-Attenuated Simian Immunodeficiency Virus Vaccine Are Associated with IL-15 Effector Functions.

Authors:  Satoru Watanabe; Masayuki Fujino; Yohei Saito; Nursarat Ahmed; Hirotaka Sato; Chie Sugimoto; Tomotaka Okamura; Kenichi Hanaki; Emi E Nakayama; Tatsuo Shioda; Kouji Matsushima; Aftab A Ansari; Francois Villinger; Kazuyasu Mori
Journal:  J Immunol       Date:  2020-08-03       Impact factor: 5.422

Review 3.  Tfh1 Cells in Germinal Centers During Chronic HIV/SIV Infection.

Authors:  Vijayakumar Velu; Geetha Mylvaganam; Chris Ibegbu; Rama Rao Amara
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.